Kirby McInerney LLP Reminds Investors That a Class Action Lawsuit Has Been Filed on Behalf of Nano-X Imaging Ltd. (NNOX) Investors and Encourages Investors to Contact the Firm Before December 6, 2021
NEW YORK, Nov 23, 2021 – (BUSINESS WIRE) – Law firm Kirby McInerney LLP is reminding investors that a class action lawsuit has been filed in the U.S. District Court for the Eastern Borough of New York on behalf of acquirers Nano-X Imaging Ltd. (“Nano-X” or the “Company”) (NASDAQ: NNOX) securities from June 17, 2021 through August 18, 2021 (the “Class Period”) inclusive. Investors have until December 6, 2021 to apply to the court to be named as the main plaintiff in the proceedings.
Nano-X is a development company that develops, manufactures, and markets digital x-ray source technology for the medical imaging industry worldwide.
On June 17, 2021, Nano-X intrigued investors when it announced it had filed a 510 (k) filing with the US Food and Drug Administration (“FDA”) to show that Nanox. ARC marketed as safe and effective and substantial is equivalent to a legally marketed device.
On August 19, 2021, Nano-X reported that the company had “received a request for additional information from the [FDA] regarding the company’s most recent 510 (k) filing for its multi-source device Nanox.ARC. The filing file will be on hold pending a full response to the FDA’s list of deficiencies. The company’s response is due within 180 days from the date of the request for additional information, 02/19/2021.
The lawsuit alleges that defendants made materially false and misleading statements about the company’s business, operational, and compliance policies during the class action period. In particular, the defendants have provided false and / or misleading information and / or failed to disclose that: (i) the 510 (k) application by Nano-X for the Nanox.ARC was defective; (ii) accordingly, it was unlikely that the FDA would approve the 510 (k) filing for Nanox.ARC in its current form; (iii) as a result, Nano-X had overstated the regulatory and commercial prospects of Nanox.ARC; and (iv) as a result, the Company’s public statements at all relevant times have been materially false and misleading.
The story goes on
If you have purchased or otherwise acquired Nano-X securities, have information, or would like to learn more about these claims, please contact Thomas W. Elrod of Kirby McInerney LLP at 212-371-6600, by email at research @ kmllp.com, or by filling out this contact form, to discuss your rights or interests in relation to these matters at no cost to you.
Kirby McInerney LLP is a New York based law firm focused on securities, antitrust, whistleblower and consumer disputes. The company’s efforts on behalf of shareholders in securities disputes have resulted in total returns of billions of dollars. For more information about the company, please visit the Kirby McInerney LLP website: http://www.kmllp.com.
This news release may be viewed as a solicitation in some jurisdictions subject to applicable laws and ethical rules.
View source version on businesswire.com: https://www.businesswire.com/news/home/20211123006207/de/
Kirby McInerney LLP
Thomas W. Elrod, Esq.